TISSIUM
LIVE

Serial Number

79258227

Owner

GECKO BIOMEDICAL

Attorney

Dmitriy O. Makarov

Filing Date

Mar 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TISSIUM Trademark

Serial Number: 79258227 • Registration: 6166178

TISSIUM is a trademark filed by GECKO BIOMEDICAL on March 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GECKO BIOMEDICAL (3 trademarks)

74 rue du Faubourg Saint Antoine

Entity Type: 33

TISSIUM (5 trademarks)

74 rue du Faubourg Saint-Antoine

Entity Type: 99

Trademark Details

Filing Date

March 12, 2019

Registration Date

October 6, 2020

Published for Opposition

July 21, 2020

Goods & Services

Pharmaceutical and pharmaceutical veterinary products for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders and for tissue reconstruction in the nature of biological tissue grafts; chemical preparations for medical, pharmaceutical, and veterinary use, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders, dental applications, drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations and for tissue reconstruction in the nature of biological tissue grafts; chemical preparations for medical, pharmaceutical, and veterinary purpose, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopaedic disorders, dental applications, drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations and for tissue reconstruction in the nature of biological tissue grafts; pre-polymers and polymers for pharmaceutical, medical, dental, and veterinary uses, in the nature of adhesives, namely, medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds, medical adhesives in the form of polymerized liquid for medical and surgical purposes to attach devices to tissue, medical adhesive in the form of polymerized liquid for medical purposes to attach devices together, drug delivery agents in the form of medical dissolvable films that facilitate the delivery of pharmaceutical preparations; sealants being medical adhesives in the form of polymerized liquid, namely, medical sealants to avoid the leakage of biological fluids and air, medical sealants to repair fissures and augment sutures and staples; filler in the nature of medical adhesives for binding internal tissues and surgical glue, namely, urogenital fillers and gastrointestinal fillers, fillers to fill hard and soft tissue defects, fillers to augment tissue and create volume, namely, injectable dermal filler and breast implants fillers, all consisting of biological materials; barriers, namely, pharmaceutical preparations for skin wounds in the nature of anti-adhesion barrier to coat tissue, protective barrier layer on skin, barrier to distribute forces across tissues, barrier to prevent tissue expansion or restrict volume, barrier to prevent infections, barrier to prevent tissue ingrowth and cell migration; and resins, namely, resins to produce resin cement through molding, extrusion or 3D printing; adhesive products for medical, surgical, dental, cosmetic, veterinary and pharmaceutical uses, namely, adhesives to bind, protect, fill and reconstruct internal and external tissue, namely, medical adhesives for binding internal tissue, medical adhesives tape, medical adhesives for binding wounds; chemical and biological preparations for medical, surgical, dental, veterinary and pharmaceutical uses, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopedic disorders, dental applications and as drug delivery agents in the form of biodegradable films that facilitate the delivery of pharmaceutical preparations; products for medical use, namely, chirurgical medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds, medical adhesives in the form of polymerized liquid for medical and surgical purposes to attach devices to tissue, medical adhesive in the form of polymerized liquid for medical purposes to attach devices together, drug delivery agents in the form of medical that facilitate the delivery of pharmaceutical preparations and diagnostic preparations for medical use; cultures of microorganisms for medical or veterinary use; enzyme preparations for medical use

Medical services; veterinary services; hygienic and beauty care for human beings and animals, consultation in pharmacy and health, namely, medical and pharmaceutical consultation; awareness-raising and information programs in the field of health, namely, providing a website featuring information about health, namely, vascular awareness and information about screening and treatment

Medical, surgical, cosmetic, veterinary and dental apparatus, instruments and devices, namely, disposable syringes, as well as open surgery, minimally invasive, interventional, endoscopic, laparoscopic surgical devices and instruments and surgical robots for use in cardiac, vascular, thoracic, gastrointestinal, neuro, urology, orthopedic, maxilo-facial, plastic and ophthalmological surgeries; suture material; prostheses, namely, medical prostheses for tissue repair and reconstruction, dental prostheses, bone prostheses, biodegradable bone fixation implants; implants consisting of artificial materials; artificial implants; syringes for medical, surgical or dental use and applicators being a component part of syringes for medical, surgical and dental applications, sold as a unit; surgical lamps; lamps for medical use, namely, polymerization light sources for medical applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposes; heating lamps for medical applications; dental care lamps, namely, polymerization light sources for dental applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposes

Biochemical and biological research services; science and technology research and development services, namely, chemical and medical chemistry research; pharmaceutical research; chemical analysis; bacteriological research; medical research; design and development of computer software and databases in the field of medicine, clinical studies; quality control services for products and preparations for medical purposes; research and development services for pharmaceutical preparations; pharmaceutical product evaluation, namely, screening service for active ingredients in the medical and pharmaceutical field; research and development services in the field of health in the nature of pharmaceuticals and biotechnology; online data collection of medical, pharmaceutical and health data using proprietary software to collect service data; online data collection with information on prevention, therapy and disease monitoring using proprietary software to collect service data; collection of data containing scientific and economic information using proprietary software to collect service data

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 6, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 25, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 25, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 6, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2020 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 2, 2020 ADCH
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 29, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 20, 2019 GNFN
FINAL REFUSAL E-MAILED
Dec 20, 2019 GNFR
FINAL REFUSAL WRITTEN
Dec 20, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2019 CRFA
ASSIGNED TO LIE
Dec 5, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 26, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2019 CNRT
ASSIGNED TO EXAMINER
May 21, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2019 REPR